| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
-
Feb 8, 2024Virtual Press Office and PR Newswire: General Trade show news
IgniteTech's AI-first approach takes the stage at the Generative AI Expo, showcasing groundbreaking initiatives such as 'AIMonday' and the innovative CoPilot features. The #TECHSUPERSHOW runs...
-
Feb 8, 2024Virtual Press Office and PR Newswire: General Trade show news
GFI Software will unveil its latest contributions to the managed services industry and how it is embracing an AI-first company culture. The #TECHSUPERSHOW runs February 13-15 in Fort Lauderdale....
-
Feb 8, 2024Virtual Press Office and PR Newswire: General Trade show news
Spyre Therapeutics, Inc. (NASDAQ: SYRE) (the "Company" or "Spyre"), a development-stage biotechnology company advancing best-in-class antibody engineering, rational therapeutic combinations, and...
-
Feb 8, 2024Virtual Press Office and PR Newswire: General Trade show news
Cyngn Inc. (the "Company" or "Cyngn") (Nasdaq: CYN) today announced that it will present at the upcoming Singular Research's Emerging Growth & Value Alpha Leaders Webinar on February 22, 2024 at...
-
Feb 8, 2024Virtual Press Office and PR Newswire: General Trade show news
AGTC-501 was generally safe and well-tolerated and showed robust improvements in visual function at the 12-month analysis Pivotal Phase 2/3 VISTA trial for AGTC-501 in XLRP expected to begin in H1...
